Avoro Capital Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-4,886,840
| Closed | -$287M | – | 53 |
|
2023
Q4 | $287M | Sell |
4,886,840
-1,779,826
| -27% | -$105M | 3.97% | 12 |
|
2023
Q3 | $290M | Buy |
6,666,666
+1,111,111
| +20% | +$48.4M | 4.53% | 11 |
|
2023
Q2 | $201M | Hold |
5,555,555
| – | – | 2.72% | 14 |
|
2023
Q1 | $207M | Hold |
5,555,555
| – | – | 3.06% | 12 |
|
2022
Q4 | $252M | Buy |
5,555,555
+5,000
| +0.1% | +$227K | 3.76% | 11 |
|
2022
Q3 | $388M | Hold |
5,550,555
| – | – | 7.16% | 4 |
|
2022
Q2 | $373M | Buy |
5,550,555
+225,555
| +4% | +$15.1M | 7.36% | 5 |
|
2022
Q1 | $438M | Buy |
5,325,000
+250,000
| +5% | +$20.6M | 7.99% | 4 |
|
2021
Q4 | $744M | Buy |
5,075,000
+75,000
| +2% | +$11M | 12.67% | 2 |
|
2021
Q3 | $885M | Hold |
5,000,000
| – | – | 13.89% | 2 |
|
2021
Q2 | $808M | Buy |
5,000,000
+325,000
| +7% | +$52.5M | 14.05% | 2 |
|
2021
Q1 | $801M | Buy |
4,675,000
+140,000
| +3% | +$24M | 13.83% | 2 |
|
2020
Q4 | $996M | Buy |
4,535,000
+192,000
| +4% | +$42.2M | 17.15% | 1 |
|
2020
Q3 | $721M | Buy |
4,343,000
+56,235
| +1% | +$9.34M | 10.25% | 2 |
|
2020
Q2 | $489M | Buy |
4,286,765
+174,065
| +4% | +$19.9M | 9.68% | 2 |
|
2020
Q1 | $316M | Buy |
4,112,700
+262,500
| +7% | +$20.2M | 10.67% | 2 |
|
2019
Q4 | $496M | Buy |
3,850,200
+100,200
| +3% | +$12.9M | 14.57% | 2 |
|
2019
Q3 | $292M | Sell |
3,750,000
-112,500
| -3% | -$8.76M | 12.19% | 1 |
|
2019
Q2 | $398M | Hold |
3,862,500
| – | – | 13.75% | 1 |
|
2019
Q1 | $283M | Sell |
3,862,500
-935,601
| -19% | -$68.6M | 12.24% | 2 |
|
2018
Q4 | $204M | Hold |
4,798,101
| – | – | 12.17% | 2 |
|
2018
Q3 | $226M | Hold |
4,798,101
| – | – | 10.38% | 2 |
|
2018
Q2 | $237M | Buy |
4,798,101
+400,000
| +9% | +$19.7M | 9.11% | 2 |
|
2018
Q1 | $135M | Hold |
4,398,101
| – | – | 6.45% | 5 |
|
2017
Q4 | $80.3M | Buy |
4,398,101
+687,500
| +19% | +$12.5M | 5.2% | 4 |
|
2017
Q3 | $43.4M | Buy |
3,710,601
+1,435,200
| +63% | +$16.8M | 3.37% | 11 |
|
2017
Q2 | $8.31M | Sell |
2,275,401
-107,800
| -5% | -$393K | 1.05% | 24 |
|
2017
Q1 | $12.4M | Buy |
2,383,201
+875,000
| +58% | +$4.55M | 1.58% | 22 |
|
2016
Q4 | $7.16M | Buy |
1,508,201
+19,714
| +1% | +$93.6K | 1.45% | 21 |
|
2016
Q3 | $9.84M | Buy |
1,488,487
+273,654
| +23% | +$1.81M | 1.73% | 19 |
|
2016
Q2 | $6.63M | Sell |
1,214,833
-189,222
| -13% | -$1.03M | 1.47% | 21 |
|
2016
Q1 | $30M | Buy |
1,404,055
+146,000
| +12% | +$3.12M | 10.48% | 1 |
|
2015
Q4 | $39.8M | Sell |
1,258,055
-195,000
| -13% | -$6.16M | 13.69% | 1 |
|
2015
Q3 | $50M | Buy |
1,453,055
+453,055
| +45% | +$15.6M | 13% | 2 |
|
2015
Q2 | $31.5M | Buy |
1,000,000
+679,133
| +212% | +$21.4M | 8.67% | 3 |
|
2015
Q1 | $9.41M | Buy |
+320,867
| New | +$9.41M | 3.61% | 9 |
|